safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
Published 3 weeks ago • 24 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
2:28
the encouraging results of the linker-mm1 trial: safety and efficacy of linvoseltamab in r/r myeloma
-
2:39
the safety and efficacy of hbi0101 for the treatment of r/r myeloma
-
4:13
real-world study determining the safety and efficacy of teclistamab in r/r multiple myeloma
-
1:13
real-world efficacy and safety of selinexor in r/r multiple myeloma
-
1:38
the safety and efficacy of belantamab mafodotin in r/r multiple myeloma in the real world
-
4:17
evaluating the safety and efficacy of elranatamab in multiple myeloma
-
1:57
the safety and efficacy of iberdomide for the treatment of multiple myeloma
-
9:25
mgus diagnosis: a step-by-step approach
-
17:55
talquetamab | therapies on the horizon
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
1:24
the safety and efficacy of elotuzumab for the treatment of multiple myeloma
-
1:47
trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
-
2:32
the safety and efficacy of isatuximab for r/r myeloma: insights from icaria-mm, ikema & candor
-
1:15
safety & efficacy of bispecific antibodies in multiple myeloma: teclistamab & elranatamb
-
1:17
efficacy & safety of standard of care cilta-cel in r/r multiple myeloma
-
2:18
efficacy and safety results from the anchor trial
-
3:23
updated safety and efficacy results of abbv-383, a novel bsab, in patients with r/r multiple myeloma
-
1:22
safety and efficacy of ari0002h for r/r mm
-
1:29
managing toxicities associated with immunotherapy in multiple myeloma
-
3:09
an overview of the toxicities associated with immunotherapy in multiple myeloma